Literature DB >> 3300834

Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.

T Gibson, P Emery, R D Armstrong, A J Crisp, G S Panayi.   

Abstract

Seventy-two patients with relatively early but progressive rheumatoid arthritis were treated with chloroquine sulphate, D-penicillamine or a combination of both drugs over 1 year. Chloroquine resulted in significantly fewer side-effects but combined treatment appeared to increase the risks of toxicity. Significant clinical improvements were seen with each regimen and these were indistinguishable between treatments. However, chloroquine had less impact on haemoglobin, ESR, rheumatoid factor levels and C-reactive protein than the other treatments. Furthermore, radiological deterioration was most frequent amongst those given chloroquine alone. Combination treatment with D-penicillamine and chloroquine thus offered no advantages. Chloroquine caused fewer side-effects than both D-penicillamine and combination treatment but appeared to have a less pronounced effect on the disease process as measured by laboratory and radiological indices.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300834     DOI: 10.1093/rheumatology/26.4.279

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  9 in total

Review 1.  Combination therapy in rheumatoid arthritis.

Authors:  S Bingham; P Emery
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Combination chemotherapy in rheumatoid arthritis.

Authors:  P M Brooks; A C Schwarzer
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

3.  Combination DMARD therapy for rheumatoid arthritis: a step closer to the goal.

Authors:  J R O'Dell
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

4.  Antagonism by D-penicillamine of the suppression of PWM-stimulated mononuclear cells by chloroquine.

Authors:  E de Vries; B A Dijkmans; H van Loenen; T M de Vreede
Journal:  Agents Actions       Date:  1989-01

5.  Intra-articular steroids: confounder of clinical trials.

Authors:  H G Taylor; P D Fowler; M J David; P T Dawes
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

Review 6.  Therapy of rheumatoid arthritis: new developments and trends.

Authors: 
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 7.  Penicillamine in rheumatoid arthritis. A problem of toxicity.

Authors:  H G Taylor; A Samanta
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

8.  Additive two DMARD therapy of the patients with rheumatoid arthritis.

Authors:  M Yasuda; S Nonaka; T Wada; M Yamamoto; S Shiokawa; Y Suenaga; M Nobunaga
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

9.  Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial.

Authors:  K L Faarvang; C Egsmose; P Kryger; J Pødenphant; M Ingeman-Nielsen; T M Hansen
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.